Roughly 30,000 Americans are diagnosed with multiple myeloma each year—a rare but serious cancer of the plasma cells. Historically treated with chemotherapy, patients often faced recurring disease and…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
NEW YORK (Reuters Health) – Duloxetine can be helpful in cancer patients who experience painful neuropathy as a sequela of treatment with neurotoxic antineoplastic agents, according to a…
NEW YORK (Reuters Health) – Over half of patients with refractory and relapsed acute lymphocytic leukemia (ALL) achieve a complete or partial response when treated with the CD22…
NEW YORK (Reuters Health) – Peridural analgesia administered during colorectal cancer resection and postoperatively is associated with improved long-term survival rates, researchers in Germany report. “The present results…
NEW YORK (Reuters Health) – A study comparing laparoscopic to open surgery for rectal cancer has confirmed the long-term oncologic safety of the laparoscopic approach. “This pooled analysis…
NEW YORK (Reuters Health) – Postsurgical radioiodine treatment (RIT) has helped many children and adolescents living in Belarus who developed advanced radiation-induced differentiated thyroid carcinoma (DTC) after the…
NEW YORK (Reuters Health) – In women previously treated for Hodgkin lymphoma, mammography is as sensitive as breast MRI in detecting breast cancer – and the two modalities…
NEW YORK (Reuters Health) – Survival among women diagnosed with breast cancer when they are pregnant is comparable to that for nonpregnant women of reproductive age treated for…
NEW YORK (Reuters Health) – A meta-analysis of 25 studies has confirmed an increased risk of cancer among children born after fertility treatment. However, “Our results do not…
NEW YORK (Reuters Health) – A European study indicates that patients with T-cell prolymphocytic leukemia may respond well to induction chemotherapy using fludarabine, mitoxantrone and cyclophosphamide, followed by…
NEW YORK (Reuters Health) – Measuring urinary levels of prostate cancer antigen 3 (PSA3) may be more accurate than PSA testing in detecting prostate cancer, but evidence is…
